- 30 June, 2025
- Posted by: Josef Cutajar
- Category: Financial News

On 30 June 2025, Stivala Group Finance p.l.c. (the “Group” or “Stivala”) announced the publication of an updated Financial Analysis Summary. The report outlines the Group's financial performance for the period from FY2022 to FY2024, and also provides projections for the financial year ending 31 December 2025.
For FY2025, Stivala is forecasting a marked improvement in revenue to €36.33 million compared to €29.48 million in FY2024. EBITDA is also expected to increase to €23.42 million from €19.53 million a year earlier. However, net profit is projected to contract significantly year-on-year to €18.10 million, down from €50.33 million in FY2024, reflecting the non-recurrence of the material profit of €30 million registered in FY2024 relating to the recognition of intangible asset.
Total assets are forecast to edge higher to €518.60 million, slightly above the €510.63 million reported as at the end of FY2024. Total equity is projected to grow to €375.33 million, up from €358.86 million. Total debt is expected to remain broadly stable at €100.41 million compared to €102.64 million in FY2024. Meanwhile, net debt is forecast to decline to €98.51 million from €101.18 million as at 31 December 2024.
The Group’s net debt-to-EBITDA multiple is forecast to trend lower to 4.21 times from 5.18 times in FY2024. Interest cover is also projected to strengthen to 5.61 times, up from 4.46 times a year earlier. The debt-to-assets ratio is expected to ease slightly to 0.19 times from 0.20 times, whilst net gearing is forecast to improve marginally to 20.79%, from 21.99% as at the end of FY2024.
Download:
Financial Analysis Summary dated 30 June 2025
Important Information:
This post is intended for the general public and is for information purposes only. The contents of this post should not be construed as an investment advice or any offer or agreement to buy or sell investments.
M.Z. Investment Services Limited of 63, MZ House, St Rita Street, Rabat RBT 1523, Malta, is regulated by the Malta Financial Services Authority and licensed to conduct investment services business in terms of the Investment Services Act (Cap. 370 of the Laws of Malta).
13 Comments
Comments are closed.
discount androxal purchase online from canada
androxal walmart price
cheapest buy rifaximin generic pharmacy online
buy rifaximin generic prices
generique kamagra pharmacie en ligne ordonnance
comprar kamagra en arg
ordering enclomiphene generic uk
how to order enclomiphene buy for cheap
cheapest buy flexeril cyclobenzaprine cheap canada pharmacy
how to buy flexeril cyclobenzaprine no prescription usa
purchase dutasteride buy from canada
compare generic dutasteride prices
will gabapentin help low testoserone
order gabapentin no prescription mastercard
canadian generic fildena
how to buy fildena generic available in united states
discount itraconazole cheap prescription
buy cheap itraconazole price in us
order avodart generic online usa
how to buy avodart cheap discount
ordering staxyn generic pricing
cheapest buy staxyn cheap prices
cheapest buy xifaxan generic online usa
ordering xifaxan cheap from canada
comprar kamagra en santiago
kamagra na lince bez lテゥkaナ冱kテゥho pナ册dpisu